A First Estimate of the Annual Prevalence of Basivertebral Nerve Ablation Candidates in a Spine Clinic.
David SherwoodScott MillerAdam EppsBenjamin GillOksana ZhivotenkoSamir KhanTheodora SwensonJames GardnerChristian RoehmerDann MartinDavid D J KennedyMichael ModicByron J SchneiderPublished in: Pain medicine (Malden, Mass.) (2022)
The population which may benefit from BVNA is small. Our study demonstrated that over a year, the prevalence for BVNA candidacy using the foundational studies criteria was 3% (95% CI 1% - 5%). While physicians may be tempted to use less stringent selection criteria in practice, upon doing so they cannot cite the foundational studies as evidence for the outcomes they expect to achieve. Those outcomes will require more studies which formally assess the benefits of BVNA when selection criteria are relaxed.